Extracorporeal Membrane Oxygenation Machine Market by Product, Component, Patient Type (Neonates, Pediatrics and Adults), Modality Outlook (Veno-Venous, Veno-Arterio and Arterio-Venous), Applications, and Region - Global Forecast to 2026

世界の体外式膜型人工肺(ECMO)装置市場予測(~2026):製品別、コンポーネント別、患者別、モダリティ別、用途別、地域別

◆タイトル:Extracorporeal Membrane Oxygenation Machine Market by Product, Component, Patient Type (Neonates, Pediatrics and Adults), Modality Outlook (Veno-Venous, Veno-Arterio and Arterio-Venous), Applications, and Region - Global Forecast to 2026
◆商品コード:MD3966
◆調査・発行会社:MarketsandMarkets
◆発行日:2021年11月26日
◆ページ数:169
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥0見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥0見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥0見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

マーケッツアンドマーケッツ社は、体外式膜型人工肺(ECMO)装置の世界市場規模が2021年531百万ドルから2026年673百万ドルまで、年平均4.9%成長すると予測しています。本調査資料では、世界の体外式膜型人工肺(ECMO)装置市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別(ECMO装置、ソフトウェア)分析、構成別(酸素供給器、制御装置、カニューレ、付属品)分析、モダリティ別(静脈-動脈、静脈-静脈、動脈-静脈)分析、患者別(新生児、小児、成人)分析、地域別分析、競争状況、企業情報などの項目を掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・体外式膜型人工肺(ECMO)装置の世界市場規模:製品別(ECMO装置、ソフトウェア)
・体外式膜型人工肺(ECMO)装置の世界市場規模:構成別(酸素供給器、制御装置、カニューレ、付属品)
・体外式膜型人工肺(ECMO)装置の世界市場規模:モダリティ別(静脈-動脈、静脈-静脈、動脈-静脈)
・体外式膜型人工肺(ECMO)装置の世界市場規模:患者別(新生児、小児、成人)
・体外式膜型人工肺(ECMO)装置の世界市場規模:地域別
・競争状況
・企業情報

“The global ECMO machine market is expected to reach USD 673 million by 2026 from an estimated USD 531 million in 2021, at a CAGR of 4.9% from 2021 to 2026.”
An ECMO machine acts as an artificial heart and lung for a patient whose own heart or lungs cannot provide enough blood flow or get enough oxygen into the blood. ECMO is used after other methods of supporting the heart and lungs do not work. The goal of the ECMO is to let the heat and lungs recover while the patient is supported by the ECMO machine. The major factors driving the growth of this market include the increasing geriatric population and growth in disease incidence as well as favorable government regulations, investments, and initiatives. The advantages of ECMO machines have played a key part in their adoption; their speed and accuracy, as well as quick processing times. This has pushed companies to focus on product development and innovation. However, these systems are priced at a premium, which slows their greater adoption. Other factors such as declining reimbursements, lack of infrastructure, particularly in developing and underdeveloped countries, and potential risks associated with radiation exposure are also expected to hinder the growth of this market.

“Respiratory segment accounted for the largest share of global ECMO machine market in 2020”
On the basis of applications, the ECMO machine market is segmented into respiratory, cardiac and ECPR applications. The respiratory segment is expected to dominate this market during the forecast period. Growth in this market can be attributed to the increasing prevalence of target diseases, high demand for early diagnosis and diagnostic imaging, and technological advancements in the ECMO machine market. Moreover, the rising prevalence of lung diseases like tuberculosis, thoracic malignancies, osteoporosis, fractures, and CVDs increases the demand for medical imaging for diagnosis.

“Arterio-Venous segment accounted for the largest market share of the ECMO machine market in 2020”
On the basis of modality, the ECMO machine market is segmented into veno-arterio, veno-venous and arterio-venous. The arterio-venous segment accounted for the larger market share. The advantages associated with this segment, such as effective dynamic range, better medical evaluation, are contributing to the growth of this technology segment.

“Increasing number of disorders/diseases in growing population resulting in an increase in the purchase of ECMO machines ”
On the basis of patient type, the ECMO machine market is segmented into neonates, pediatric and adults. The adult segment contributed to the largest share of global ECMO machine market in 2020. ECMO has been used for more than 40 years, and its benefits with neonates with respiratory distress are well recognized. The benefits of ECMO in adult patients with cardiac or respiratory failure are still debated, as ECMO was initially associated with low survival rates. However, recent technological advancements in ECMO circuits have led to a reduction in the rate of technical issues and complications.

“Controllers, by component, have contributed the largest share in the ECMO machine market”
Based on component, the global ECMO machine market is segmented into pumps, oxygenators, controllers, cannula and accessories. The controllers segment is expected to dominate the market during the forecast period. The large share of this segment can be attributed to the greater adoption of the systems among end users due to their lowercost compared to others.
“Portable Segment, by product type, has commanded the highest growth rate in the forecast period”
Based on product type, the ECMO machine market is segmented into Static ECMO machines and Portable ECMO machines. Portable ECMO machine segment is expected to dominate the market during the forecast period. Portable ECMO machines can be transported to any desired location and they re light in weight. These systems are especially used in a variety of imaging-set ups, including intensive care units, cardiac care units, neonatal intensive care units, operating rooms, emergency rooms, and at the patient’s beside for critically ill patients or patients with mobility challenges.

“The APAC market, by region, to register highest growth rate in the forecast period”
The ECMO Machine market is segmented into five major regions—North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The asia-pacific market is expected to register the highest growth in the forecast period. Growth in the ECMO machine market in the Asia Pacific is mainly driven by the growing geriatric population, particularly in Japan; increasing disposable incomes, allowing for greater affordability for advanced technologies; the rising prevalence of target diseases; and favorable government initiatives. Such factors help to drive the market for digital imaging systems in this region and draw foreign investments and partnerships. On the other hand, low hospital budgets, high equipment costs, and a lack of government investments in some countries are limiting the growth of the market in the Asia Pacific to a certain extent.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–25%, Tier 2–37%, and Tier 3– 38%
• By Designation: C-level–34%, Director-level–35%, and Others–31%
• By Region: North America–24%, Europe–32%, Asia Pacific–28%, Latin America–10%, and the Middle East & Africa–6%

The ECMO machine market is dominated by Fresenius Medical care AG & Co. KGaA(Germany), Getinge Group (Sweden), Microport (China). Other leading market players include Medtronic pls (US), Terumo cardiovascular Systems Corporation (Japan), Nipro Corporation (Japan), and Livanova plc (UK).

Research Coverage
This report studies the ECMO machine market based on patient type, application, product, compnent, modality outlook and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:
 Market Penetration: Comprehensive information on the product portfolios offered by the top players in the ECMO machine market
 Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the ECMO machine market
 Market Development: Comprehensive information on lucrative emerging regions
 Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the ECMO machine market
 Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

【レポートの目次】

1 INTRODUCTION 25
1.1 OBJECTIVES OF THE STUDY 25
1.2 MARKET DEFINITION 25
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 26
1.3 MARKETS SCOPE 26
1.3.1 MARKETS COVERED 26
FIGURE 1 ECMO MARKET SEGMENTATION 26
1.3.2 YEARS CONSIDERED FOR THE STUDY 27
1.4 CURRENCY USED FOR THE STUDY 27
1.5 KEY MARKET STAKEHOLDERS 27
1.6 SUMMARY OF CHANGES 28
2 RESEARCH METHODOLOGY 29
2.1 RESEARCH DATA 29
FIGURE 2 RESEARCH DESIGN 29
2.1.1 SECONDARY DATA SOURCES 30
2.1.1.1 Indicative list of secondary sources 31
2.1.2 PRIMARY DATA 32
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION AND REGION 33
2.2 MARKET SIZE ESTIMATION METHODOLOGY 33
FIGURE 4 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 34
2.3 MARKET DATA VALIDATION AND TRIANGULATION 35
FIGURE 5 DATA TRIANGULATION METHODOLOGY 35
2.4 KEY RESEARCH ASSUMPTIONS 36
2.5 LIMITATIONS 36
2.5.1 METHODOLOGY-RELATED LIMITATIONS 36
2.6 RISK ASSESSMENT 37
TABLE 1 RISK ASSESSMENT: ECMO MARKET 37
2.7 GROWTH RATE ASSUMPTIONS 37
2.8 COVID-19 HEALTH ASSESSMENT 37
2.9 COVID-19 ECONOMIC ASSESSMENT 37
2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 38
FIGURE 6 CRITERIA IMPACTING THE GLOBAL ECONOMY 38
FIGURE 7 RECOVERY SCENARIO OF THE GLOBAL ECONOMY (2021–2022) 39

3 EXECUTIVE SUMMARY 40
FIGURE 8 ECMO MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION) 40
FIGURE 9 ECMO MARKET SHARE, BY MODALITY, 2021 VS. 2026 40
FIGURE 10 ECMO MARKET, BY COMPONENT, 2021 VS. 2026 (USD MILLION) 41
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE ECMO MARKET 42
4 PREMIUM INSIGHTS 43
4.1 ECMO MARKET OVERVIEW 43
FIGURE 12 RISING PREVALENCE OF TARGET DISEASES TO DRIVE MARKET GROWTH 43
4.2 ECMO MARKET SHARE, BY REGION AND PATIENT TYPE (2020) 44
FIGURE 13 NORTH AMERICA DOMINATED THE ECMO MARKET IN 2020 44
4.3 ECMO MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION) 44
FIGURE 14 ECMO MACHINES SEGMENT WILL CONTINUE TO DOMINATE
THE ECMO MARKET DURING THE FORECAST PERIOD 44
4.4 ECMO MARKET: GEOGRAPHIC SNAPSHOT 45
FIGURE 15 EMERGING MARKETS ARE ESTIMATED TO REGISTER HIGHER GROWTH RATES THAN DEVELOPED MARKETS 45
5 MARKET OVERVIEW 46
5.1 INTRODUCTION 46
5.2 MARKET DYNAMICS 46
FIGURE 16 ECMO MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 46
5.2.1 DRIVERS 47
5.2.1.1 Increasing prevalence of cardiovascular and respiratory diseases 47
TABLE 2 NUMBER OF DEATHS FROM CARDIOVASCULAR AND RESPIRATORY DISEASES ACROSS THE GLOBE, 1990 VS. 2019 47
5.2.1.2 Growing adoption of ECMO in lung transplantation procedures 47
5.2.1.3 Growth in the number of ECMO centers 48
TABLE 3 GLOBAL INCREASE IN THE NUMBER OF ECMO CENTERS 48
5.2.1.4 Technological advancements in ECMO machines 48
5.2.2 RESTRAINTS 49
5.2.2.1 Complications associated with ECMO 49
5.2.2.2 High cost of ECMO procedures 49
TABLE 4 AVERAGE COST OF ECMO IN VARIOUS COUNTRIES 49
5.2.3 OPPORTUNITIES 50
5.2.3.1 Increasing survival rates with ECMO 50
5.2.4 CHALLENGES 50
5.2.4.1 Shortage of skilled professionals 50
5.2.4.2 Eligibility issues for ECMO 50
5.2.4.3 Issues related to selecting the right equipment 50
5.2.4.4 Risks related to the transport of ECMO patients 51
5.2.4.5 Issues related to treatment decision-making 51

5.3 REGULATORY LANDSCAPE 51
TABLE 5 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING
THE ECMO MARKET 51
5.3.1 NORTH AMERICA 52
5.3.1.1 US 52
TABLE 6 CLASSIFICATION OF MEDICAL DEVICES BY US FDA 52
5.3.1.2 Canada 53
5.3.2 EUROPE 53
5.3.3 ASIA PACIFIC 53
5.3.3.1 India 53
5.3.3.2 Japan 53
TABLE 7 CLASSIFICATION OF MEDICAL DEVICES AND THE REVIEWING BODY IN JAPAN 54
5.3.3.3 China 54
TABLE 8 NMPA MEDICAL DEVICE CLASSIFICATION 55
5.4 COVID-19 IMPACT ON THE ECMO MARKET 55
5.4.1 REIMBURSEMENT SCENARIO 55
5.5 PATENT ANALYSIS 56
5.5.1 PATENTS GRANTED FOR ECMO MACHINES 56
TABLE 9 PATENTS GRANTED FROM 2016 TO 2021 57
5.5.2 PUBLICATION TRENDS FOR PATENTS ON ECMO MACHINES 57
TABLE 10 FILED PATENTS, 2000–2021 57
TABLE 11 GRANTED PATENTS, 2010–2021 58
TABLE 12 PUBLISHED PATENTS, 2016–2021 58
5.6 VALUE CHAIN ANALYSIS 58
FIGURE 17 VALUE CHAIN OF THE ECMO MARKET 59
5.7 PRICING TREND ANALYSIS 59
TABLE 13 AVERAGE PRICE OF ECMO, BY COUNTRY, 2020 (USD) 59
5.8 PORTER’S FIVE FORCES ANALYSIS 60
TABLE 14 ECMO MARKET: PORTER’S FIVE FORCES ANALYSIS 60
5.8.1 THREAT OF NEW ENTRANTS 60
FIGURE 18 THREAT OF NEW ENTRANTS 60
5.8.2 THREAT OF SUBSTITUTES 61
FIGURE 19 THREAT OF SUBSTITUTES 61
5.8.3 BARGAINING POWER OF SUPPLIERS 61
FIGURE 20 BARGAINING POWER OF SUPPLIERS 62
5.8.4 BARGAINING POWER OF BUYERS 62
FIGURE 21 BARGAINING POWER OF BUYERS 62
5.8.5 INTENSITY OF COMPETITIVE RIVALRY 63
FIGURE 22 INTENSITY OF COMPETITIVE RIVALRY 63
5.9 ECOSYSTEM LANDSCAPE 63
FIGURE 23 ECMO MARKET: ECOSYSTEM LANDSCAPE 64

6 EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY PRODUCT 65
6.1 INTRODUCTION 66
TABLE 15 ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 66
6.2 ECMO MACHINES 66
6.2.1 STATIC ECMO MACHINES SEGMENT TO DOMINATE
THE ECMO MACHINES MARKET 66
TABLE 16 ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION) 66
TABLE 17 ECMO MACHINES MARKET, BY REGION, 2018–2026 (USD MILLION) 67
TABLE 18 ECMO MACHINES MARKET, BY COMPONENT, 2018–2026 (USD MILLION) 67
TABLE 19 ECMO MACHINES MARKET, BY MODALITY, 2018–2026 (USD MILLION) 67
TABLE 20 ECMO MACHINES MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION) 68
TABLE 21 ECMO MACHINES MARKET, BY APPLICATION, 2018–2026 (USD MILLION) 68
6.2.2 PORTABLE ECMO MACHINES 68
TABLE 22 PORTABLE ECMO MACHINES MARKET, BY REGION,
2018–2026 (USD MILLION) 68
TABLE 23 PORTABLE ECMO MACHINES MARKET, BY COMPONENT,
2018–2026 (USD MILLION) 69
TABLE 24 PORTABLE ECMO MACHINES MARKET, BY MODALITY,
2018–2026 (USD MILLION) 69
TABLE 25 PORTABLE ECMO MACHINES MARKET, BY PATIENT TYPE,
2018–2026 (USD MILLION) 69
TABLE 26 PORTABLE ECMO MACHINES MARKET, BY APPLICATION,
2018–2026 (USD MILLION) 70
6.2.3 STATIC ECMO MACHINES 70
TABLE 27 STATIC ECMO MACHINES MARKET, BY REGION, 2018–2026 (USD MILLION) 70
TABLE 28 STATIC ECMO MACHINES MARKET, BY COMPONENT,
2018–2026 (USD MILLION) 70
TABLE 29 STATIC ECMO MACHINES MARKET, BY MODALITY,
2018–2026 (USD MILLION) 71
TABLE 30 STATIC ECMO MACHINES MARKET, BY PATIENT TYPE,
2018–2026 (USD MILLION) 71
TABLE 31 STATIC ECMO MACHINES MARKET, BY APPLICATION,
2018–2026 (USD MILLION) 71
6.3 SOFTWARE 72
6.3.1 SOFTWARE SEGMENT TO GROW AT A STEADY CAGR DURING
THE FORECAST PERIOD 72
TABLE 32 ECMO SOFTWARE MARKET, BY REGION, 2018–2026 (USD MILLION) 72
TABLE 33 ECMO SOFTWARE MARKET, BY MODALITY, 2018–2026 (USD MILLION) 72
TABLE 34 ECMO SOFTWARE MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION) 72
TABLE 35 ECMO SOFTWARE MARKET, BY APPLICATION, 2018–2026 (USD MILLION) 73

7 EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY COMPONENT 74
7.1 INTRODUCTION 75
TABLE 36 ECMO MARKET, BY COMPONENT, 2018–2026 (USD MILLION) 75
7.2 PUMPS 75
7.2.1 CENTRIFUGAL BLOOD PUMPS HAVE BECOME THE PUMP OF CHOICE FOR ADULT EXTRACORPOREAL LIFE SUPPORT 75
TABLE 37 ECMO MARKET FOR PUMPS, BY REGION, 2018–2026 (USD MILLION) 75
7.3 OXYGENATORS 76
7.3.1 PMP OXYGENATORS HAVE SIGNIFICANTLY LESS PRIMING VOLUME 76
TABLE 38 ECMO MARKET FOR OXYGENATORS, BY REGION, 2018–2026 (USD MILLION) 76
7.4 CONTROLLERS 76
7.4.1 CONTROLLERS ALLOW OPERATORS OF ECMO CIRCUITS TO ADJUST THE SETTINGS AS NEEDED 76
TABLE 39 ECMO MARKET FOR CONTROLLERS, BY REGION, 2018–2026 (USD MILLION) 77
7.5 CANNULAS 77
7.5.1 THE CHOICE OF CANNULAS IS IMPORTANT IN ECMO PROCEDURES 77
TABLE 40 ECMO MARKET FOR CANNULAS, BY REGION, 2018–2026 (USD MILLION) 77
7.6 ACCESSORIES 78
TABLE 41 ECMO MARKET FOR ACCESSORIES, BY REGION, 2018–2026 (USD MILLION) 78
8 EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY MODALITY 79
8.1 INTRODUCTION 80
TABLE 42 ECMO MARKET, BY MODALITY, 2018–2026 (USD MILLION) 80
8.2 VENOARTERIAL ECMO 80
8.2.1 INCREASING INCIDENCE OF HEART-LUNG FAILURE TO DRIVE
THE GROWTH OF THIS MARKET SEGMENT 80
TABLE 43 VENOARTERIAL ECMO MARKET, BY REGION, 2018–2026 (USD MILLION) 81
8.3 VENOVENOUS ECMO 81
8.3.1 VENOVENOUS ECMO IS USED WHEN ADEQUATE
HEART FUNCTION IS AVAILABLE 81
TABLE 44 VENOVENOUS ECMO MARKET, BY REGION, 2018–2026 (USD MILLION) 81
8.4 ARTERIOVENOUS ECMO 82
8.4.1 ARTERIOVENOUS ECMO MACHINES ARE SMALLER AND MORE PORTABLE 82
TABLE 45 ARTERIOVENOUS ECMO MARKET, BY REGION, 2018–2026 (USD MILLION) 82
9 EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY PATIENT TYPE 83
9.1 INTRODUCTION 84
TABLE 46 COMMON INDICATIONS FOR ECMO IN NEONATES, PEDIATRIC
PATIENTS, AND ADULTS 84
TABLE 47 ECMO MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION) 84
9.2 NEONATES 85
9.2.1 A LARGE NUMBER OF NEONATES ARE CARED FOR WITH ECMO WORLDWIDE 85
TABLE 48 ECMO MARKET FOR NEONATES, BY REGION, 2018–2026 (USD MILLION) 85
9.3 PEDIATRIC PATIENTS 86
9.3.1 PEDIATRIC PATIENTS FORM A LARGE PATIENT GROUP FOR ECMO PROCEDURES 86
TABLE 49 ECMO MARKET FOR PEDIATRIC PATIENTS, BY REGION,
2018–2026 (USD MILLION) 86
9.4 ADULTS 86
9.4.1 TECHNOLOGICAL ADVANCEMENTS ARE DRIVING THE USE
OF ECMO IN ADULT PATIENTS 86
TABLE 50 ECMO MARKET FOR ADULTS, BY REGION, 2018–2026 (USD MILLION) 87
10 EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY APPLICATION 88
10.1 INTRODUCTION 89
TABLE 51 ECMO MARKET, BY APPLICATION, 2018–2026 (USD MILLION) 89
10.2 RESPIRATORY APPLICATIONS 89
TABLE 52 ECMO MARKET FOR RESPIRATORY APPLICATIONS, BY REGION,
2018–2026 (USD MILLION) 89
10.2.1 RESPIRATORY APPLICATIONS FOR NEONATES 90
TABLE 53 NUMBER OF NEONATES RECEIVING ECMO SUPPORT FOR RESPIRATORY APPLICATIONS 90
10.2.2 RESPIRATORY APPLICATIONS FOR PEDIATRIC PATIENTS 90
TABLE 54 NUMBER OF PEDIATRIC PATIENTS RECEIVING ECMO SUPPORT FOR RESPIRATORY APPLICATIONS 90
10.2.3 RESPIRATORY APPLICATIONS FOR ADULTS 90
TABLE 55 NUMBER OF ADULTS RECEIVING ECMO SUPPORT
FOR RESPIRATORY APPLICATIONS 90
10.3 CARDIAC APPLICATIONS 91
TABLE 56 ECMO MARKET FOR CARDIAC APPLICATIONS, BY REGION,
2018–2026 (USD MILLION) 91
10.3.1 CARDIAC APPLICATIONS FOR ADULTS 91
10.3.2 CARDIAC APPLICATIONS FOR PEDIATRIC PATIENTS 91
10.3.3 CARDIAC APPLICATIONS FOR NEONATES 91
10.4 EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR) 92
TABLE 57 ECMO MARKET FOR ECPR APPLICATIONS, BY REGION,
2018–2026 (USD MILLION) 92
10.4.1 ECPR APPLICATIONS FOR ADULTS 92
10.4.2 ECPR APPLICATIONS FOR PEDIATRIC PATIENTS 92
10.4.3 ECPR APPLICATIONS FOR NEONATES 93
11 EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY REGION 94
11.1 INTRODUCTION 95
TABLE 58 ECMO MARKET, BY REGION, 2018–2026 (USD MILLION) 95
11.2 NORTH AMERICA 95
FIGURE 24 NORTH AMERICA: ECMO MARKET SNAPSHOT 96
TABLE 59 NORTH AMERICA: ECMO MARKET, BY COUNTRY, 2018–2026 (USD MILLION) 96
TABLE 60 NORTH AMERICA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 97
TABLE 61 NORTH AMERICA: ECMO MACHINES MARKET, BY TYPE,
2018–2026 (USD MILLION) 97
TABLE 62 NORTH AMERICA: ECMO MARKET, BY COMPONENT,
2018–2026 (USD MILLION) 97
TABLE 63 NORTH AMERICA: ECMO MARKET, BY MODALITY, 2018–2026 (USD MILLION) 98
TABLE 64 NORTH AMERICA: ECMO MARKET, BY PATIENT TYPE,
2018–2026 (USD MILLION) 98
TABLE 65 NORTH AMERICA: ECMO MARKET, BY APPLICATION,
2018–2026 (USD MILLION) 98
11.2.1 US 99
11.2.1.1 US accounted for the largest share of the North American market 99
TABLE 66 US: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 99
TABLE 67 US: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION) 99
11.2.2 CANADA 100
11.2.2.1 Implementation of the ABF model in Canadian hospitals to drive market growth 100
TABLE 68 CANADA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 100
TABLE 69 CANADA: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION) 100
11.3 EUROPE 101
TABLE 70 EUROPE: ECMO MARKET, BY COUNTRY, 2018–2026 (USD MILLION) 101
TABLE 71 EUROPE: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 101
TABLE 72 EUROPE: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION) 101
TABLE 73 EUROPE: ECMO MARKET, BY COMPONENT, 2018–2026 (USD MILLION) 102
TABLE 74 EUROPE: ECMO MARKET, BY MODALITY, 2018–2026 (USD MILLION) 102
TABLE 75 EUROPE: ECMO MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION) 102
TABLE 76 EUROPE: ECMO MARKET, BY APPLICATION, 2018–2026 (USD MILLION) 103
11.3.1 GERMANY 103
11.3.1.1 Increasing volume of ECMO procedures to drive market
growth in Germany 103
TABLE 77 GERMANY: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 103
TABLE 78 GERMANY: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION) 103
11.3.2 FRANCE 104
11.3.2.1 Rising healthcare spending to drive market growth in France 104
TABLE 79 FRANCE: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 104
TABLE 80 FRANCE: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION) 104
11.3.3 UK 104
11.3.3.1 Rising adoption of ECMO procedures and increasing prevalence of lifestyle diseases to drive market growth in the UK 104
TABLE 81 UK: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 105
TABLE 82 UK: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION) 105
11.3.4 ITALY 105
11.3.4.1 High burden of CVDs contributing to the growth of the ECMO market in Italy 105
TABLE 83 ITALY: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 106
TABLE 84 ITALY: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION) 106
11.3.5 SPAIN 106
11.3.5.1 High adoption of advanced technologies to drive market
growth in Spain 106
TABLE 85 SPAIN: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 107
TABLE 86 SPAIN: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION) 107
11.4 REST OF EUROPE 107
TABLE 87 REST OF EUROPE: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 107
TABLE 88 REST OF EUROPE: ECMO MACHINES MARKET, BY TYPE,
2018–2026 (USD MILLION) 108
11.5 ASIA PACIFIC 108
FIGURE 25 ASIA PACIFIC: ECMO MARKET SNAPSHOT 108
TABLE 89 ASIA PACIFIC: ECMO MARKET, BY COUNTRY, 2018–2026 (USD MILLION) 109
TABLE 90 ASIA PACIFIC: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 109
TABLE 91 ASIA PACIFIC: ECMO MACHINES MARKET, BY TYPE,
2018–2026 (USD MILLION) 109
TABLE 92 ASIA PACIFIC: ECMO MARKET, BY COMPONENT, 2018–2026 (USD MILLION) 110
TABLE 93 ASIA PACIFIC: ECMO MARKET, BY MODALITY, 2018–2026 (USD MILLION) 110
TABLE 94 ASIA PACIFIC: ECMO MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION) 110
TABLE 95 ASIA PACIFIC: ECMO MARKET, BY APPLICATION, 2018–2026 (USD MILLION) 111
11.5.1 JAPAN 111
11.5.1.1 Favorable healthcare infrastructure in Japan to drive market growth 111
TABLE 96 JAPAN: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 111
TABLE 97 JAPAN: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION) 112
11.5.2 CHINA 112
11.5.2.1 Rising geriatric population and increasing prevalence of
CVD to drive market growth in China 112
TABLE 98 CHINA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 113
TABLE 99 CHINA: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION) 113
11.5.3 INDIA 113
11.5.3.1 Growing applications and rising adoption of ECMO to drive market growth in India 113
TABLE 100 INDIA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 113
TABLE 101 INDIA: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION) 114
11.5.4 AUSTRALIA 114
11.5.4.1 Technological advancements to drive market growth in Australia 114
TABLE 102 AUSTRALIA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 114
TABLE 103 AUSTRALIA: ECMO MACHINES MARKET, BY TYPE,
2018–2026 (USD MILLION) 114
11.5.5 SOUTH KOREA 115
11.5.5.1 Increasing incidence of cardiac disorders to drive market growth in South Korea 115
TABLE 104 SOUTH KOREA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 115
TABLE 105 SOUTH KOREA: ECMO MACHINES MARKET, BY TYPE,
2018–2026 (USD MILLION) 115
11.5.6 REST OF APAC 115
TABLE 106 REST OF APAC: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 116
TABLE 107 REST OF APAC: ECMO MACHINES MARKET, BY TYPE,
2018–2026 (USD MILLION) 116
11.6 LATIN AMERICA 116
TABLE 108 LATIN AMERICA: ECMO MARKET, BY COUNTRY, 2018–2026 (USD MILLION) 116
TABLE 109 LATIN AMERICA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 117
TABLE 110 LATIN AMERICA: ECMO MACHINES MARKET, BY TYPE,
2018–2026 (USD MILLION) 117
TABLE 111 LATIN AMERICA: ECMO MARKET, BY COMPONENT,
2018–2026 (USD MILLION) 117
TABLE 112 LATIN AMERICA: ECMO MARKET, BY MODALITY, 2018–2026 (USD MILLION) 118
TABLE 113 LATIN AMERICA: ECMO MARKET, BY PATIENT TYPE,
2018–2026 (USD MILLION) 118
TABLE 114 LATIN AMERICA: ECMO MARKET, BY APPLICATION,
2018–2026 (USD MILLION) 118
11.6.1 BRAZIL 119
11.6.1.1 Rising adoption of ECMO as a bridge to heart and lung transplantation to drive market growth in Brazil 119
TABLE 115 BRAZIL: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 119
TABLE 116 BRAZIL: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION) 119
11.6.2 MEXICO 120
11.6.2.1 High burden of CVDs in the country to drive market growth in Mexico 120
TABLE 117 MEXICO: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 120
TABLE 118 MEXICO: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION) 120
11.6.3 REST OF LATIN AMERICA 121
TABLE 119 REST OF LATIN AMERICA: ECMO MARKET, BY PRODUCT,
2018–2026 (USD MILLION) 121
TABLE 120 REST OF LATIN AMERICA: ECMO MACHINES MARKET, BY TYPE,
2018–2026 (USD MILLION) 121
11.6.4 MIDDLE EAST & AFRICA 121
11.6.4.1 Increasing prevalence of target diseases to drive market growth in the Middle East & Africa 121
TABLE 121 MIDDLE EAST & AFRICA: ECMO MARKET, BY PRODUCT,
2018–2026 (USD MILLION) 122
TABLE 122 MIDDLE EAST & AFRICA: ECMO MACHINES MARKET, BY TYPE,
2018–2026 (USD MILLION) 122
TABLE 123 MIDDLE EAST & AFRICA: ECMO MARKET, BY COMPONENT,
2018–2026 (USD MILLION) 122
TABLE 124 MIDDLE EAST & AFRICA: ECMO MARKET, BY MODALITY,
2018–2026 (USD MILLION) 123
TABLE 125 MIDDLE EAST & AFRICA: ECMO MARKET, BY PATIENT TYPE,
2018–2026 (USD MILLION) 123
TABLE 126 MIDDLE EAST & AFRICA: ECMO MARKET, BY APPLICATION,
2018–2026 (USD MILLION) 123
12 COMPETITIVE LANDSCAPE 124
12.1 INTRODUCTION 124
FIGURE 26 KEY DEVELOPMENTS BY LEADING PLAYERS IN THE ECMO MARKET,
2018–2021 124
12.2 REVENUE SHARE ANALYSIS 125
FIGURE 27 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE ECMO MARKET 125
12.3 MARKET SHARE ANALYSIS 126
FIGURE 28 ECMO MARKET SHARE, BY KEY PLAYER, 2020 126
TABLE 127 ECMO MARKET: DEGREE OF COMPETITION 126
12.4 COMPETITIVE LEADERSHIP MAPPING: COMPANY EVALUATION QUADRANT (2020) 127
12.4.1 TERMINOLOGY/NOMENCLATURE 127
12.4.1.1 Stars 127
12.4.1.2 Emerging leaders 127
12.4.1.3 Pervasive players 128
12.4.1.4 Participants 128
FIGURE 29 ECMO MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020 128
12.5 COMPETITIVE LEADERSHIP MAPPING: START-UP/SME EVALUATION QUADRANT (2020) 129
12.5.1 PROGRESSIVE COMPANIES 129
12.5.2 RESPONSIVE COMPANIES 129
12.5.3 DYNAMIC COMPANIES 129
12.5.4 STARTING BLOCKS 129
FIGURE 30 ECMO MARKET: COMPETITIVE LEADERSHIP MAPPING FOR
SMES/START-UPS, 2020 130
12.6 COMPETITIVE BENCHMARKING 131
TABLE 128 PRODUCT FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE ECMO MARKET 131
TABLE 129 APPLICATION FOOTPRINT ANALYSIS OF THE TOP PLAYERS
IN THE ECMO MARKET 132
TABLE 130 COMPANY FOOTPRINT ANALYSIS IN THE ECMO MARKET 133
12.7 COMPETITIVE SCENARIO (2018–2021) 134
12.7.1 NEW PRODUCT LAUNCHES & APPROVALS 134
13 COMPANY PROFILES 135
13.1 KEY PLAYERS 135
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
13.1.1 FRESENIUS MEDICAL CARE AG & CO. KGAA 135
TABLE 131 FRESENIUS MEDICAL CARE AG & CO. KGAA: BUSINESS OVERVIEW 135
FIGURE 31 FRESENIUS MEDICAL CARE AG & CO. KGAA: COMPANY SNAPSHOT 136
TABLE 132 FRESENIUS MEDICAL CARE AG & CO. KGAA: PRODUCT OFFERINGS 136
TABLE 133 FRESENIUS MEDICAL CARE AG & CO. KGAA: PRODUCT LAUNCHES 137
13.1.2 GETINGE GROUP 138
TABLE 134 GETINGE GROUP: BUSINESS OVERVIEW 138
FIGURE 32 GETINGE GROUP: COMPANY SNAPSHOT 139
TABLE 135 GETINGE GROUP: PRODUCT OFFERINGS 140
13.1.3 MEDTRONIC PLC 141
TABLE 136 MEDTRONIC PLC: BUSINESS OVERVIEW 141
FIGURE 33 MEDTRONIC PLC: COMPANY SNAPSHOT 142
TABLE 137 MEDTRONIC PLC: PRODUCT OFFERINGS 142
13.1.4 MICROPORT 144
TABLE 138 MICROPORT: BUSINESS OVERVIEW 144
FIGURE 34 MICROPORT: COMPANY SNAPSHOT 145
TABLE 139 MICROPORT: PRODUCT OFFERINGS 145
13.1.5 TERUMO CARDIOVASCULAR SYSTEMS CORPORATION 146
FIGURE 35 TERUMO CARDIOVASCULAR SYSTEMS CORPORATION: COMPANY SNAPSHOT 146
TABLE 140 TERUMO CARDIOVASCULAR SYSTEMS CORPORATION: BUSINESS OVERVIEW 147
TABLE 141 TERUMO CARDIOVASCULAR SYSTEMS CORPORATION: PRODUCT OFFERINGS 147
13.1.6 NIPRO CORPORATION 148
TABLE 142 NIPRO CORPORATION: BUSINESS OVERVIEW 148
FIGURE 36 NIPRO CORPORATION: COMPANY SNAPSHOT 149
TABLE 143 NIPRO CORPORATION: PRODUCT OFFERINGS 149
13.1.7 LIVANOVA PLC 150
TABLE 144 LIVANOVA PLC.: BUSINESS OVERVIEW 150
FIGURE 37 LIVANOVA PLC.: COMPANY SNAPSHOT 151
TABLE 145 LIVANOVA PLC: PRODUCT OFFERINGS 151
13.1.8 EUROSETS S.R.L. 152
TABLE 146 EUROSETS S.R.L.: BUSINESS OVERVIEW 152
TABLE 147 EUROSETS S.R.L.: PRODUCT OFFERINGS 152
13.1.9 ORIGEN BIOMEDICAL, INC. 153
TABLE 148 ORIGEN BIOMEDICAL, INC.: BUSINESS OVERVIEW 153
TABLE 149 ORIGEN BIOMEDICAL, INC.: PRODUCT OFFERINGS 153
13.1.10 CYTOSORBENTS CORPORATION 154
TABLE 150 CYTOSORBENTS CORPORATION: BUSINESS OVERVIEW 154
TABLE 151 CYTOSORBENTS CORPORATION: PRODUCT OFFERINGS 154
13.1.11 ABIOMED 155
TABLE 152 ABIOMED: BUSINESS OVERVIEW 155
TABLE 153 ABIOMED: PRODUCT OFFERINGS 155
13.1.12 BRAILE BIOMÉDICA 156
TABLE 154 BRAILE BIOMÉDICA: BUSINESS OVERVIEW 156
TABLE 155 BRAILE BIOMÉDICA: PRODUCT OFFERINGS 156
13.1.13 SPECTRUM MEDICAL 157
TABLE 156 SPECTRUM MEDICAL: BUSINESS OVERVIEW 157
TABLE 157 SPECTRUM MEDICAL: PRODUCT OFFERINGS 157
13.1.14 HAEMONETICS 158
TABLE 158 HAEMONETICS: BUSINESS OVERVIEW 158
TABLE 159 HAEMONETICS: PRODUCT OFFERINGS 158
13.1.15 XENIOS AG 159
TABLE 160 XENIOS AG: BUSINESS OVERVIEW 159
TABLE 161 XENIOS AG: PRODUCT OFFERINGS 159
TABLE 162 XENIOS AG: PRODUCT LAUNCHES 160
13.1.16 KANEKA CORPORATION 161
TABLE 163 KANEKA CORPORATION: BUSINESS OVERVIEW 161
TABLE 164 KANEKA CORPORATION: PRODUCT OFFERINGS 161
13.1.17 SB-KAWASUMI LABORATORIES, INC. 162
TABLE 165 SB-KAWASUMI LABORATORIES, INC.: BUSINESS OVERVIEW 162
TABLE 166 SB-KAWASUMI LABORATORIES, INC.: PRODUCT OFFERINGS 162
13.1.18 WEIGAO GROUP 163
TABLE 167 WEIGAO GROUP: BUSINESS OVERVIEW 163
TABLE 168 WEIGAO GROUP: PRODUCT OFFERINGS 163
13.1.19 ZHENGYUAN TECHNOLOGY 164
TABLE 169 ZHENGYUAN TECHNOLOGY: BUSINESS OVERVIEW 164
TABLE 170 ZHENGYUAN TECHNOLOGY: PRODUCT OFFERINGS 164
13.1.20 BREETHE, INC. 165
TABLE 171 BREETHE, INC.: BUSINESS OVERVIEW 165
TABLE 172 BREETHE, INC.: PRODUCT OFFERINGS 165
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
14 APPENDIX 166
14.1 DISCUSSION GUIDE 166
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 170
14.3 AVAILABLE CUSTOMIZATIONS 172
14.4 RELATED REPORTS 172
14.5 AUTHOR DETAILS 174



★調査レポート[世界の体外式膜型人工肺(ECMO)装置市場予測(~2026):製品別、コンポーネント別、患者別、モダリティ別、用途別、地域別] ( Extracorporeal Membrane Oxygenation Machine Market by Product, Component, Patient Type (Neonates, Pediatrics and Adults), Modality Outlook (Veno-Venous, Veno-Arterio and Arterio-Venous), Applications, and Region - Global Forecast to 2026 / MD3966) 販売に関する免責事項
[世界の体外式膜型人工肺(ECMO)装置市場予測(~2026):製品別、コンポーネント別、患者別、モダリティ別、用途別、地域別] ( Extracorporeal Membrane Oxygenation Machine Market by Product, Component, Patient Type (Neonates, Pediatrics and Adults), Modality Outlook (Veno-Venous, Veno-Arterio and Arterio-Venous), Applications, and Region - Global Forecast to 2026 / MD3966) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆